CDKN2A and cervical carcinoma: CDKN2A can also prevent the progression of cervical cancer since patients frequently have hypermethylated CDKN2A. The absence of p16INK4A protein inhibits the expression of HPV E7 oncoprotein and cervical cancer progression.